These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16226609)

  • 1. Undue inducement.
    Glantz L; Grodin M
    Lancet; 2005 Oct 15-21; 366(9494):1356-7. PubMed ID: 16226609
    [No Abstract]   [Full Text] [Related]  

  • 2. Undue inducement in clinical research in developing countries: is it a worry?
    Emanuel EJ; Currie XE; Herman A;
    Lancet; 2005 Jul 23-29; 366(9482):336-40. PubMed ID: 16039339
    [No Abstract]   [Full Text] [Related]  

  • 3. Undue inducement in clinical research.
    Martin R
    Lancet; 2005 Jul 23-29; 366(9482):275-6. PubMed ID: 16039318
    [No Abstract]   [Full Text] [Related]  

  • 4. "Undue inducement' as coercive offers.
    McGregor J
    Am J Bioeth; 2005; 5(5):24-5. PubMed ID: 16179302
    [No Abstract]   [Full Text] [Related]  

  • 5. Undue fear of inducements in research in developing countries.
    Arnason G; Van Niekerk A
    Camb Q Healthc Ethics; 2009 Apr; 18(2):122-9. PubMed ID: 19250565
    [No Abstract]   [Full Text] [Related]  

  • 6. Benefits to research subjects in international trials: do they reduce exploitation or increase undue inducement?
    Ballantyne A
    Dev World Bioeth; 2008 Dec; 8(3):178-91. PubMed ID: 19046255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guest editorial: vulnerability revisited.
    Schroeder D; Arnason G
    Camb Q Healthc Ethics; 2009 Apr; 18(2):110-1. PubMed ID: 19250563
    [No Abstract]   [Full Text] [Related]  

  • 8. Universal and uniform protection of human subjects in research: also a fallacy in some developing countries.
    Outomuro D
    Am J Bioeth; 2008 Nov; 8(11):19-20. PubMed ID: 19061101
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter to the editor: Would you know an undue inducement if you saw one?
    Schwab AP
    Am J Bioeth; 2005; 5(5):W17. PubMed ID: 16179291
    [No Abstract]   [Full Text] [Related]  

  • 10. Compensating clinical trial participants from limited resource settings in internationally sponsored clinical trials: a proposal.
    Ndebele P; Mfutso-Bengo J; Mduluza T
    Malawi Med J; 2008 Jun; 20(2):42-5. PubMed ID: 19537431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contextualizing the vulnerability standard.
    Shivas T
    Am J Bioeth; 2004; 4(3):84-6; discussion W32. PubMed ID: 16192157
    [No Abstract]   [Full Text] [Related]  

  • 12. Undue inducement: nonsense on stilts?
    Emanuel EJ
    Am J Bioeth; 2005; 5(5):9-13; discussion W8-11, W17. PubMed ID: 16179296
    [No Abstract]   [Full Text] [Related]  

  • 13. Human experimentation in developing countries: improving international practices by identifying vulnerable populations and allocating fair benefits.
    Farrell K
    J Health Care Law Policy; 2006; 9(1):136-61. PubMed ID: 17165228
    [No Abstract]   [Full Text] [Related]  

  • 14. Undue inducement: the only objection to payment?
    VanderWalde A
    Am J Bioeth; 2005; 5(5):25-7. PubMed ID: 16179303
    [No Abstract]   [Full Text] [Related]  

  • 15. For-profit clinical trials in developing countries--those troublesome patient benefits.
    Schuklenk U
    Am J Bioeth; 2010 Jun; 10(6):52-4. PubMed ID: 20526975
    [No Abstract]   [Full Text] [Related]  

  • 16. Vulnerability: a needed moral safeguard.
    DeMarco JP
    Am J Bioeth; 2004; 4(3):82-4; discussion W32. PubMed ID: 16192156
    [No Abstract]   [Full Text] [Related]  

  • 17. International ethical guidelines for biomedical research involving human subjects.
    Council for International Organizations of Medical Sciences
    Bull Med Ethics; 2002 Oct; (182):17-23. PubMed ID: 14983848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vulnerability to influence: a two-way street.
    Henderson GE; Davis AM; King NM
    Am J Bioeth; 2004; 4(3):50-2; discussion W32. PubMed ID: 16192139
    [No Abstract]   [Full Text] [Related]  

  • 19. Money for research participation: does in jeopardize informed consent?
    Grady C
    Am J Bioeth; 2001; 1(2):40-4. PubMed ID: 11951886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In that case: your company has invested heavily in developing an AIDS vaccine and wishes to embark on clinical trials. Commentary.
    Evans D
    N Z Bioeth J; 2001 Oct; 2(3):37-8. PubMed ID: 15587008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.